Showing 6541-6550 of 19355 results for "".
Evolving Approaches to Early-Onset CRC Detection
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/evolving-early-onset-crc-detection/49175/How can we address the growing challenge of early-onset colorectal cancer? Find out as Ryan Quigley sits down with Dr. Peter Buch to review practical strategies and emerging innovations that could help us improve screening uptake in younger adults. Dr. Buch is a board-certified clinical gastroenteroThe Case for Prioritizing Patient Reacquisition
https://reachmd.com/series/c-suite-chats/the-case-for-prioritizing-patient-reacquisition/56424/Susie Kozlowski, Business Development Manager for Brevium, explains the importance of patient reacquisition for a dermatology practice.Challenging the Status Quo in Schizophrenia Treatment
https://reachmd.com/programs/frontlines-schizophrenia/challenging-status-quo-schizophrenia/54154/Schizophrenia care is at a turning point. As novel therapies and psychosocial interventions begin to challenge long-standing approaches, clinicians and patients are looking forward to a future of optimized care and improved long-term outcomes. Tune in to hear Dr. Stephen Marder in conversation withThe Social Brain in Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/the-social-brain-in-schizophrenia/54155/Social dysfunction is a core and often early feature of schizophrenia that affects how individuals interpret social cues, regulate emotions, and engage with others in daily life. Advances in social processes and neuroscience have identified brain networks involved in emotion recognition and mentalizNutrition and the Gut-Brain Connection in Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/nutrition-gut-brain-connection-schizophrenia/54157/What if food could influence brain function in schizophrenia? Emerging research into the gut–brain connection suggests that inflammation, immune responses, and cellular energy metabolism may play a meaningful role in psychiatric symptoms—and that targeted dietary strategies could offer new therapeutFAI and the Future of Cardiac Risk Stratification
https://reachmd.com/programs/clinicians-roundtable/fai-future-cardiac-risk/54806/Pericoronary fat attenuation index (FAI) may enhance risk stratification in patients with coronary heart disease by capturing vascular inflammation. In this AudioAbstract, Ryan Quigley shares how integrating FAI into clinical models could support more precise, individualized cardiovascular risk aTracking Disease Progression in ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/tracking-disease-progression-in-attr-cm/49037/Disease progression in transthyretin amyloid cardiomyopathy (ATTR-CM) isn’t as straightforward as it once seemed. While newer therapies are helping patients live longer and better, recognizing when the disease is subtly worsening requires more than waiting for a hospitalization—it means paying attenAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
https://reachmd.com/programs/clinicians-roundtable/relapse-prediction-pediatric-aml-genomic-mrd/54352/Emerging research suggests genomic minimal residual disease (MRD) could be a more sensitive and stable approach to predicting relapse in pediatric acute myeloid leukemia (AML). Ryan Quigley sits down with Dr. Amanda Winters to learn more about how this method could aid in earlier interventioCoding for Superficial Radiation Therapy
https://reachmd.com/series/c-suite-chats/coding-for-superficial-radiation-therapy/56364/Joseph C. Sardano, Chairman and CEO of Sensus Healthcare, discusses the issue of insurance denials for noninvasive skin cancer treatments such as superficial radiation therapy (SRT), and a new solution for ensuring predictable payment.The Burden of Cognitive Dysfunction in Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/the-burden-of-cognitive-dysfunction-in-multiple-sclerosis/54238/Cognitive impairment affects a significant portion of patients with multiple sclerosis and can impact academic and professional performance. Hear Dr. Christopher Lock discuss how multiple sclerosis-related cognitive changes may present in practice, and how timely evaluation and supportive interventi